What Inhibikase Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 1 |
| Sells | 0 | 0 |
| Total trades | 2 | 6 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 21,854 | 2,090,819 |
| Disposed | 18,030,000 | 18,642,670 |
| Net activity | −18,008,146 | −16,551,851 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Berman Dennis N | Director | Jul 30 | Exercise / conversion · M | +21,854 | $1.26 | +$27.5K | 21,854 |
| Ra Capital MANAGEMENT, L.p. | 10% owner | Jul 29 | Other Transaction · J | −18,030,000 | — | — | 6,970,000 |
| Munshi Amit | Director | Feb 21 | Disposition to Issuer · D | −19,089 | — | — | 38,176 |
| Vincent Aurentz | Director | Feb 21 | Disposition to Issuer · D | −255,299 | — | — | 510,596 |
| Cabell Christopher | President & Head of R&D | Feb 21 | Disposition to Issuer · D | −338,282 | — | — | 676,564 |
| Sands Capital Life Sciences Pulse Fund II, L.p. | 10% owner | Nov 21 | Open-market buy · P | +2,068,965 | $1.45 | +$3M | 13,018,965 |
| Munshi Amit | Director | Feb 21 | Grant / award · A | +57,265 | — | — | 57,265 |
| Bellini Roberto | Director | Oct 21 | Open-market buy · P | +1,460,000 | $1.37 | +$2M | 1,460,000 |
| Munshi Amit | Director | Oct 21 | Open-market buy · P | +365,000 | $1.37 | +$500K | 365,000 |
| Kush Arvind | Director | Oct 21 | Open-market buy · P | +145,000 | $1.37 | +$199K | 145,000 |
| Werner Milton H. | President and CEO | Aug 16 | Open-market buy · P | +5,000 | $0.80 | +$4K | 5,335,433 |
| Werner Milton H. | President and CEO | May 27 | Open-market buy · P | +5,000 | $0.98 | +$4.88K | 5,330,433 |
| Werner Milton H. | President and CEO | May 20 | Open-market buy · P | +10,000 | $0.60 | +$6K | 5,325,433 |
| Frattaroli Joseph | Chief Financial Officer | May 19 | Open-market buy · P | +3,948 | $0.64 | +$2.54K | 48,091 |
| Werner Milton H. | President and CEO | Jan 03 | Exercise / conversion · M | +21,853 | $2.02 | +$44.1K | 5,315,433 |
| Werner Milton H. | President and CEO | Nov 17 | Open-market buy · P | +400 | $1.93 | +$772 | 23,589 |
| Werner Milton H. | President and CEO | Nov 17 | Open-market buy · P | +1,334 | $1.94 | +$2.59K | 23,589 |
| Werner Milton H. | President and CEO | Nov 17 | Open-market buy · P | +3,186 | $1.96 | +$6.24K | 23,589 |
| Werner Milton H. | President and CEO | Nov 17 | Open-market buy · P | +1,100 | $1.97 | +$2.17K | 23,589 |
| Werner Milton H. | President and CEO | Nov 17 | Open-market buy · P | +17,569 | $1.98 | +$34.8K | 23,589 |
Loading...
